Patents Assigned to Kiyoshi Takatsu
  • Patent number: 5916767
    Abstract: The invention provides an isolated cDNA sequence coding for murine interleukin 5 receptor, murine secretory interleukin 5 receptor, human interleukin 5 receptor, and human secretory interleukin 5 receptor and products including murine interleukin 5 receptor, murine secretory interleukin 5 receptor, and human interleukin 5 receptor which are produced using the isolated cDNA sequence. These products may be useful for a therapeutic agent for autoimmune disorders and diseases with eosinophilia in which human IL-5 is believed to be involved.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: June 29, 1999
    Assignee: Kiyoshi Takatsu
    Inventors: Kiyoshi Takatsu, Akira Tominaga, Satoshi Takagi, Yoshiyuki Murata
  • Patent number: 5807991
    Abstract: The invention provides an isolated cDNA sequence coding for murine interleukin 5 receptor, murine secretory interleukin 5 receptor, human interleukin 5 receptor, and human secretory interleukin 5 receptor and products including murine interleukin 5 receptor, murine secretory interleukin 5 receptor, and human interleukin 5 receptor which are produced using the isolated cDNA sequence. These products may be useful for a therapeutic agent for autoimmune disorders and diseases with eosinophilia in which human IL-5 is believed to be involved.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: September 15, 1998
    Assignee: Kiyoshi Takatsu
    Inventors: Kiyoshi Takatsu, Akira Tominaga, Satoshi Takagi, Yoshiyuki Murata
  • Patent number: 5760204
    Abstract: The invention provides an isolated cDNA sequence coding for murine interleukin 5 receptor, murine secretory interleukin 5 receptor, human interleukin 5 receptor, and human secretory interleukin 5 receptor and products including murine interleukin 5 receptor, murine secretory interleukin 5 receptor, and human interleukin 5 receptor which are produced using the isolated cDNA sequence. These products may be useful for a therapeutic agent for autoimmune disorders and diseases with eosinophilia in which human IL-5 is believed to be involved.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: June 2, 1998
    Assignee: Kiyoshi Takatsu
    Inventors: Kiyoshi Takatsu, Akira Tominaga, Satoshi Takagi
  • Patent number: 5453491
    Abstract: The invention provides an isolated cDNA sequence coding for murine interleukin 5 receptor, murine secretory interleukin 5 receptor, human interleukin 5 receptor, and human secretory interleukin 5 receptor and products including murine interleukin 5 receptor, murine secretory interleukin 5 receptor, and human interleukin 5 receptor which are produced using the isolated cDNA sequence. These products may be useful for a therapeutic agent for autoimmune disorders and diseases with eosinophilia in which human IL-5 is believed to be involved.
    Type: Grant
    Filed: September 10, 1991
    Date of Patent: September 26, 1995
    Assignee: Kiyoshi Takatsu
    Inventors: Kiyoshi Takatsu, Akiro Tominaga, Satoshi Takagi, Yoshiyuki Murata